These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes. Javadi MA; Feizi S; Karbasian A; Rastegarpour A Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763 [TBL] [Abstract][Full Text] [Related]
24. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651 [TBL] [Abstract][Full Text] [Related]
25. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats]. Zhang W; Pan Z; Zhai C Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts. Unal M; Yücel I Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913 [TBL] [Abstract][Full Text] [Related]
27. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial. Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400 [TBL] [Abstract][Full Text] [Related]
31. [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty]. Bailly N; Dunewa I; Schlattmann P; Rieck PW Ophthalmologe; 2008 May; 105(5):457-62. PubMed ID: 18299847 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G; Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740 [TBL] [Abstract][Full Text] [Related]
33. Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty. Fei WL; Chen JQ; Yuan J; Quan DP; Zhou SY J Ocul Pharmacol Ther; 2008 Apr; 24(2):235-44. PubMed ID: 18321198 [TBL] [Abstract][Full Text] [Related]
34. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study. Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469 [TBL] [Abstract][Full Text] [Related]
36. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Price MO; Price FW Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779 [TBL] [Abstract][Full Text] [Related]
38. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220 [TBL] [Abstract][Full Text] [Related]
39. Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids. Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Latifi G; Dehghani S; Haq Z; Djalilian AR Cornea; 2017 Oct; 36(10):1195-1199. PubMed ID: 28817391 [TBL] [Abstract][Full Text] [Related]
40. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. Wiesner RH Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]